Out of Date or Best Before? A Commentary on the Relevance of Economic Evaluations Over Time
- 6 December 2021
- journal article
- research article
- Published by Springer Nature in PharmacoEconomics
- Vol. 40 (3) , 249-256
Abstract
The impact of time on the applicability and relevance of historical economic evaluations can be considerable. Ignoring this may lead to the use of weak or invalid evidence to inform important research questions or resource allocation decisions, as historical economic evaluations may have reached different conclusions compared to if a similar study had been conducted more recently. There are multiple factors that contribute towards evidence becoming outdated including changes to the relevant decision problem (e.g. comparators), changes to parameters (such as costs, utilities and resource use) and methodological updates (e.g. recommendations on uncertainty analysis). Researchers reviewing economic evaluations need to consider whether changes over time would influence the study design and results if the evaluation were repeated, to the extent that it is no longer helpful or informative. In this paper, we summarise these key issues and make recommendations about how and whether researchers can future proof their economic evaluations.Keywords
This publication has 46 references indexed in Scilit:
- The evolution of three decades of antiretroviral therapy: challenges, triumphs and the promise of the futureBritish Journal of Clinical Pharmacology, 2015
- Long-term cost-effectiveness analysis of endovascular versus open repair for abdominal aortic aneurysm based on four randomized clinical trialsBritish Journal of Surgery, 2014
- Consolidated Health Economic Evaluation Reporting Standards (CHEERS) statementBMJ, 2013
- The UK EndoVascular Aneurysm Repair (EVAR) trials: randomised trials of EVAR versus standard therapy.Health Technology Assessment, 2012
- Network meta-analysis of survival data with fractional polynomialsBMC Medical Research Methodology, 2011
- Whither trial‐based economic evaluation for health care decision making?Health Economics, 2006
- Cost-effectiveness of endovascular abdominal aortic aneurysm repairBritish Journal of Surgery, 2005
- Development and Validation of a Grading System for the Quality of Cost-Effectiveness StudiesMedical Care, 2003
- The death of cost‐minimization analysis?Health Economics, 2001
- Guidelines for authors and peer reviewers of economic submissions to the BMJBMJ, 1996